Laxmi Dental Peer Comparison
NSE: LAXMIDENTL | BSE: 544339
₹177.58
As on 30-Oct-2026IST
Market cap
₹978 Cr
Revenue (TTM)
₹287 Cr
P/E Ratio
31.7
P/B Ratio
4
Div. Yield
0 %
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
978 | 51,112 | 6,967 | 63 | 29 |
Revenue (₹ Cr) |
287 | 6,725 | 7,587 | 21 | 150 |
Net Profit (₹ Cr) |
28.67 | 1,128.79 | 211.00 | 3.24 | 5.63 |
Net Margin (%) |
9.68 | 16.02 | 2.75 | 15.18 | 3.69 |
RoE (%) |
9.14 | 11.51 | 10.44 | 19.12 | 6.65 |
Price to Earnings |
31.67 | 45.28 | 33.01 | 19.58 | 9.06 |
Price-To-Book |
3.99 | 4.81 | 3.37 | 3.41 | 0.54 |
Income Statement (₹ Cr)
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Operating Revenue
|
277.86 | 6,430.65 | 6,892.47 | 16.80 | 149.06 |
|
Total Income
|
286.40 | 6,746.98 | 6,963.79 | 16.93 | 151.31 |
|
Total Expenditure
|
233.97 | 4,801.11 | 6,268.09 | 14.47 | 140.44 |
|
EBITDA
|
43.89 | 1,629.54 | 624.38 | 2.34 | 8.62 |
|
Depreciation
|
15.88 | 423.67 | 282.87 | 0.81 | 3.24 |
|
EBIT
|
28.02 | 1,205.88 | 341.51 | 1.53 | 5.38 |
|
Interest
|
1.86 | 33.28 | 137.50 | 0.61 | 2.67 |
|
Other Income
|
8.55 | 316.33 | 71.32 | 0.12 | 2.24 |
|
Exceptional Items
|
-5.78 | -24.35 | -- | -- | -1.79 |
|
Profit before Tax
|
28.93 | 1,464.58 | 275.33 | 1.04 | 3.10 |
|
Provision for Tax
|
2.50 | 437.26 | 55.72 | 0.29 | 0.08 |
|
Profit after Tax
|
26.43 | 1,027.32 | 219.61 | 0.75 | 3.03 |
Liabilities (₹ Cr)
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
243.32 | 10,357.95 | 1,975.36 | 13.78 | 52.83 |
|
Minority Interest
|
0.79 | -- | -0.71 | 0.00 | 2.05 |
|
Non-Current Liabilities
|
14.83 | 482.17 | 1,225.00 | -0.07 | 10.02 |
|
Current Liabilities
|
30.79 | 1,608.40 | 763.90 | 8.87 | 71.19 |
|
Total Liabilities
|
300.10 | 12,448.52 | 4,084.80 | 23.05 | 136.09 |
Assets (₹ Cr)
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
101.01 | 4,921.74 | 1,820.29 | 5.39 | 28.13 |
|
Current Assets
|
188.72 | 7,526.79 | 2,143.26 | 17.19 | 107.96 |
|
Total Assets
|
300.10 | 12,448.52 | 4,084.80 | 23.05 | 136.09 |
|
Total Debt*
|
0.00 | 243.36 | 0.00 | 5.07 | 11.66 |
|
Net Current Assets
|
157.93 | 5,918.38 | 1,379.36 | 8.32 | 36.77 |
|
Contingent Liabilities
|
-- | 10.12 | 14.06 | 0.42 | 8.97 |
Cashflow (₹ Cr)
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-5.00 | 1,031.39 | 495.58 | -0.01 | -3.81 |
|
Cash Flow from Investing Activities
|
-79.58 | 137.73 | -127.72 | -0.04 | 9.00 |
|
Cash from Financing Activities
|
-17.75 | -416.97 | -255.51 | 0.19 | -5.55 |
|
Net Cash Inflow / Outflow
|
-102.33 | 752.14 | 112.36 | 0.14 | -0.35 |
Ratios
Profitability Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.29 | 14.96 | 22.22 | 9.13 | 8.82 |
|
ROE (%)
|
11.95 | 10.56 | 11.93 | 5.59 | 5.77 |
|
ROA (%)
|
9.31 | 8.70 | 6.00 | 3.42 | 2.28 |
|
EBIT Margin (%)
|
18.87 | 30.26 | 10.09 | 14.64 | 7.29 |
|
Net Margin (%)
|
9.23 | 15.23 | 3.15 | 4.43 | 2.00 |
|
Cash Profit Margin (%)
|
15.23 | 22.56 | 7.19 | 9.27 | 4.20 |
Growth Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
16.21 | 14.50 | 12.33 | -23.76 | 36.77 |
|
EBIT Growth (%)
|
14.03 | 31.25 | 26.01 | -59.17 | 848.46 |
|
Net Profit Growth (%)
|
4.16 | 47.07 | 46.18 | -77.67 | 142.76 |
|
EPS Growth (%)
|
-8.79 | 47.07 | 45.68 | -77.67 | 117.30 |
|
Book Value Growth (%)
|
14.31 | 12.70 | 14.76 | 5.75 | 1.53 |
Valuation Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Price / Earnings
|
29.86 | 27.22 | 45.79 | 29.91 | 21.72 |
|
Price / Book Value
|
3.67 | 2.71 | 5.11 | 1.63 | 0.50 |
|
Dividend Yield (%)
|
0.00 | 1.18 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
16.32 | 12.77 | 13.79 | 10.73 | 3.06 |
|
Market Cap (₹ Cr)
|
865.33 | 27,964.97 | 10,057.49 | 22.43 | 26.46 |
Solvency Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.02 | 0.00 | 0.37 | 0.22 |
|
Short term debt to equity ratio
|
-- | -- | -- | 0.33 | 0.14 |
|
Current Ratio
|
6.13 | 4.68 | 2.81 | 1.94 | 1.52 |
|
Quick Ratio
|
5.42 | 3.60 | 1.00 | 1.15 | 0.75 |
|
Interest Coverage
|
16.57 | 45.01 | 3.00 | 2.71 | 2.16 |
Operating Efficiency Ratios
| Laxmi Dental | Gland Pharma | Medplus Health | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
16.39 | 29.41 | 0.39 | 39.46 | 30.10 |
|
Asset Turnover
|
0.98 | 0.54 | 1.91 | 0.77 | 1.12 |
|
Receivable days
|
54.00 | 96.72 | 1.05 | 122.59 | 86.14 |
|
Inventory Days
|
26.54 | 97.32 | 71.25 | 138.71 | 128.56 |
|
Payable days
|
94.91 | 134.60 | 21.75 | 36.89 | 165.50 |
|
Cash Conversion Cycle
|
-14.37 | 59.43 | 50.55 | 224.42 | 49.21 |